| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |